SCHWARZ PHARMA, Inc Company Profile

23:25 EDT 3rd August 2015 | BioPortfolio

SCHWARZ PHARMA, Inc. is the U.S. headquarters of SCHWARZ PHARMA AG, a mid-sized, multi-national pharmaceutical company focusing on the development and marketing of innovative therapeutics. SCHWARZ PHARMA leverages its strengths to secure new product flow through collaborative alliances with academia, research organizations and biotech companies. This development strategy is supported and funded by the established position of SCHWARZ PHARMA as a global pharmaceutical company with a marketing presence in all key international markets.

Location

6140 W Executive Dr
Mequon
Wisconsin
53092
United States of America

Contact

Email: mdi@schwarzusa.com


News Articles [923 Associated News Articles listed on BioPortfolio]

German stocks - Factors to watch on February 24

FRANKFURT, Feb 24 (Reuters) - Germany's DAX top-30 index was set to open unchanged on Tuesday, according to premarket data from brokerage Lang & Schwarz at 0733 GMT.

German stocks - Factors to watch on May 22

FRANKFURT, May 22 (Reuters) - The DAX top-30 index looked set to open 0.1 percent higher on Friday, according to premarket data from brokerage Lang & Schwarz at 0614 GMT.

German stocks - Factors to watch on May 26

FRANKFURT, May 26 (Reuters) - The DAX top-30 index looked set to open 0.1 percent lower on Tuesday, according to premarket data from brokerage Lang & Schwarz at 0608 GMT.

German stocks - Factors to watch on May 8

FRANKFURT, May 8 (Reuters) - The DAX top-30 index looked set to open 0.6 percent higher on Friday, according to pre-market data from brokerage Lang & Schwarz at 0631 GMT.

German stocks - Factors to watch on May 27

FRANKFURT, MAY 27(Reuters) - The DAX top-30 index looked set to open 0.2 percent higher on Wednesday, according to premarket data from brokerage Lang & Schwarz at 0542 GMT.

German stocks - Factors to watch on February 20

FRANKFURT, Feb 20 (Reuters) - Germany's DAX top-30 index was set to open 0.2 percent lower on Friday, according to premarket data from brokerage Lang & Schwarz at 0703 GMT.

German stocks - Factors to watch on February 17

FRANKFURT/BERLIN, Feb 17 (Reuters) - Germany's DAX top-30 index was poised to open down 0.7 on Tuesday, according to premarket data from brokerage Lang & Schwarz at 0737 GMT.

German stocks - Factors to watch on July 28

FRANKFURT, Jul 28 (Reuters) - The DAX top-30 index looked set to open 0.4 percent higher on Tuesday according to premarket data from brokerage Lang & Schwarz at 0628 GMT.

Drugs and Medications [248 Associated Drugs and Medications listed on BioPortfolio]

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 0.5 mg

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 1 mg

Metoprolol tartrate [Med-Health Pharma, LLC]

Metoprolol Tartrate Tablets, USP

Urea [Libertas Pharma, Inc.]

Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )

Eloxatin [Aventis Pharma Ltd.]

PubMed Articles [25 Associated PubMed Articles listed on BioPortfolio]

Discovery of a novel trimebutine metabolite and its impact on N-desmethyltrimebutine quantification by LC-MS/MS.

Hélène Montpetit has a Bachelor of Science in Biochemistry from the University du Québec at Montreal. For the past 15 years, she has worked in the bioanalysis field in CROs environment as well as i...

In response to the letter by Schwarz GL et al. concerning the paper by Heesen M et al.

Response to: 'Paracetamol: is all the concern valid?' by Schwarz and Mullins.

10 years after implementation of TRIPS obligations in India.

The Patent (Amendment) Act of 2005 enforced after TRIPS raises many issues which hinder growth of Indian pharma companies. To tackle this, Indian pharma companies doubled their R&D expenditure and bec...

Pharmaceutical industry, academia and patient advocacy organizations: What is the recipe for synergic (win-win-win) collaborations?

Biological complexity and the need for highly differentiated medicines means that drug discovery and development have become increasingly challenging and expensive. Thus, new paradigms for research an...

Clinical Trials [56 Associated Clinical Trials listed on BioPortfolio]

A Relative Bioavailability Study of Moexipril HCl 15 mg Tablets Under Fasting Conditions

The purpose of this study is to compare the relative bioavailability of Moexipril HCl 15mg tablets (by Paddock Laboratories, Inc.) with that of Univasc® 15mg tablets (by Schwarz Pharma) f...

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.

A Bioequivalence Study of Cefadroxil From Duricef 1 gm F.C.T (GSK) and Biodroxil 1 gm F.C.T (Novartis Pharma)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Cefadroxil from Duricef 1 gm Film Coated tablets(Smthkline Beecham Egypt,LLC aff...

Pharma-Pen (Formerly Innoject) Auto-Injectory TIV

The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...

To Demonstrate the Relative Bioavailability of Cilostazol 50 mg Tablets Under Fasting Conditions

To demonstrate the relative bioavailability of Cilostazol 50 mg tablets under fasting conditions.

Companies [668 Associated Companies listed on BioPortfolio]

SCHWARZ PHARMA, Inc

SCHWARZ PHARMA, Inc. is the U.S. headquarters of SCHWARZ PHARMA AG, a mid-sized, multi-national pharmaceutical company focusing on the development and marketing of innovative therapeutics. SCHWARZ PHA...

Schwarz Pharma Spain

Nuestros esfuerzos se concentran en las áreas terapéuticas del sistema nervioso central, el sistema cardiovascular y urología. SCHWARZ PHARMA desarrolla y comercializa medicamentos innovadores para...

SCHWARZ PHARMA Deutschland GmbH

SCHWARZ PHARMA AG is a publicly traded company, which develops and markets innovative drugs with the focus on Central Nervous System (CNS) as well as cardiovascular and gastro-intestinal diseases empl...

SCHWARZ PHARMA AG

SCHWARZ PHARMA AG is a publicly traded company, which develops and markets innovative drugs with the focus on Central Nervous System (CNS) as well as cardiovascular and gastro-intestinal diseases empl...

H3 Pharma Incorporated

H3 Pharma Inc. is a Venture Pharma focusing on the development of human therapeutic products oriented towards age-related disorders. At H3 Pharma, we aim to be the best at identifying, evaluating and ...

More Information about "SCHWARZ PHARMA, Inc" on BioPortfolio

We have published hundreds of SCHWARZ PHARMA, Inc news stories on BioPortfolio along with dozens of SCHWARZ PHARMA, Inc Clinical Trials and PubMed Articles about SCHWARZ PHARMA, Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of SCHWARZ PHARMA, Inc Companies in our database. You can also find out about relevant SCHWARZ PHARMA, Inc Drugs and Medications on this site too.


Advertisement
 

Relevant Topic

Biotechnology - Biotech
Latest News Clinical Trials Research Drugs Reports Corporate
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record